Neuronetics, Inc. (NASDAQ: STIM) watched its stock make slight gains Monday. The medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, announced enhancements to the TrakStar® Patient Data Management System, a proprietary, HIPAA-compliant, patient management and outcomes reporting system for NeuroStar transcranial magnetic stimulation (TMS) providers.
The Malvern, Pa.-based company adds the update introduces a range of automated features to improve communication between providers and their existing and prospective patients, while also saving practices time in recording and documenting results. This marks the second significant upgrade to the platform this year.
Included among the TrakStar developments are a customizable survey and patient check-in dashboard that fully automates scheduled health surveys and motivational messages for patients at various stages of their NeuroStar treatment. To facilitate seamless utilization of the automated SMS texting and email features, TrakStar makes it convenient to update patient contact details in one location. Additionally, a new export feature effortlessly shares or saves patient survey results if needed by insurance providers or for storing in an electronic medical record system.
According to CEO Keith Sullivan, “The enhancements we’ve made to our industry-defining TrakStar system allow practices to continue to elevate the standard of patient care they provide. With the latest updates,
NeuroStar providers can more easily connect with their patients using automated SMS text messaging, a new avenue for communication that can save practices time and support patients through their treatment process.”
STIM shares were up six cents, or 3.4%, at $1.82.
Related Stories
